J. Blay

发表

Sarcomas and malignant phyllodes tumours of the breast--a retrospective study.

P. Biron, I. Ray-Coquard, P. Thiesse, 2006, European journal of cancer.

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, S. Bonvalot, O. Mir, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: A randomized controlled open-label trial

A. Cesne, I. Ray-Coquard, N. Isambert, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.

J. Blay, F. Bertucci, A. Cesne, 2019, European journal of cancer.

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

J. Blay, F. Collin, R. Sciot, 2010, British Journal of Cancer.

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study.

J. Blay, F. Grosso, A. Cesne, 2011, European journal of cancer.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

J. Blay, F. Bertucci, B. Bui, 2010, British Journal of Cancer.

Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.

A. Cesne, O. Mir, J. Adam, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

J. Blay, A. Cesne, A. Le Cesne, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies

M. Mehren, H. Gelderblom, S. Stacchiotti, 2023, ESMO open.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.

J. Blay, J. Radford, J. Verweij, 2001, European journal of cancer.

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.

J. Blay, F. Bertucci, B. Bui, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.